SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-24 Cr | ₹-25 Cr | ₹-24 Cr | ₹1.09 Cr | ₹3.21 Cr |
What is the latest Cash Flow from Financing Activities ratio of SURAKSHA DIAGNOSTIC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-24 Cr |
| Mar2024 | ₹-25 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹1.09 Cr |
| Mar2021 | ₹3.21 Cr |
How is Cash Flow from Financing Activities of SURAKSHA DIAGNOSTIC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-24 Cr | Negative | |
| Mar2024 | ₹-25 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹1.09 Cr | -66.15 | |
| Mar2021 | ₹3.21 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,443.7 Cr | -1.5% | -1.3% | -13.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹119,392.0 Cr | 2.5% | 7.1% | 19.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹95,090.8 Cr | 4.1% | -3.8% | -14.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹73,174.3 Cr | 4.4% | 1.2% | 33% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,260.1 Cr | 3.5% | 7.1% | 11.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹39,045.6 Cr | 4.5% | 3.1% | 32% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | -1.5% |
-1.3% |
-13.5% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses